Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 4 for:    Miriam Mintzer
Previous Study | Return to List | Next Study

Effects of Meditation

This study has been terminated.
(The Principal Investigator is leaving Johns Hopkins.)
Sponsor:
Information provided by (Responsible Party):
Miriam Mintzer, Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT01827033
First received: March 29, 2013
Last updated: November 25, 2013
Last verified: November 2013
  Purpose

This research is being done to learn about the effects of doing meditation (sitting quietly and concentrating) on people's ability to pay attention and be relaxed.


Condition Intervention
Meditation Training
Behavioral: meditation training

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment

Further study details as provided by Johns Hopkins University:

Primary Outcome Measures:
  • computerized attention task [ Time Frame: within 1 week after training ] [ Designated as safety issue: No ]
    discrimination score on the continuous performance task


Secondary Outcome Measures:
  • stress questionnaires [ Time Frame: within 1 week after training ] [ Designated as safety issue: No ]
  • mindfulness questionnaire [ Time Frame: within 1 week after training ] [ Designated as safety issue: No ]

Enrollment: 6
Study Start Date: March 2013
Estimated Study Completion Date: March 2015
Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
meditation training Behavioral: meditation training

  Eligibility

Ages Eligible for Study:   18 Years to 55 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • aged 18-55
  • currently enrolled in methadone maintenance program

Exclusion Criteria:

  • history of: a severe medical or psychiatric condition (except substance abuse; e.g., schizophrenia); brain trauma affecting cognitive functioning
  • prior experience with meditation
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01827033

Locations
United States, Maryland
BPRU, Johns Hopkins Bayview Medical Center
Baltimore, Maryland, United States, 21224
Sponsors and Collaborators
Johns Hopkins University
Investigators
Principal Investigator: Miriam Z Mintzer, PhD Johns Hopkins University
  More Information

No publications provided

Responsible Party: Miriam Mintzer, Associate Professor, Johns Hopkins University
ClinicalTrials.gov Identifier: NCT01827033     History of Changes
Other Study ID Numbers: NA_00082735
Study First Received: March 29, 2013
Last Updated: November 25, 2013
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on November 20, 2014